AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

Drug Free Solution, Inc.

$0.00 -$0.00 (-63.64%)
OTC · 30 Oct 2026 20:00 UTC
Previous Close
$0.00
Day Range
$0.00$0.00
Year Range
$0.00$0.04
Market Cap
113.36K
AVG Volume
591
Trailing/Forward PE
-16.94/-
PEG ratio
-0.17
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · Q
00.511.5212 Q212 Q312 Q413 Q113 Q213 Q320 Q324 Q1
DSOL Revenue (USD) by quarter
PeriodRevenue (USD)
24 Q10
20 Q30
13 Q30
13 Q22
13 Q10
12 Q40
12 Q30
12 Q20
Net Income (USD) · Q
-10K-7.5K-5K-2.5K012 Q212 Q312 Q413 Q113 Q213 Q320 Q324 Q1
DSOL Net Income (USD) by quarter
PeriodNet Income (USD)
24 Q1-8.41K
20 Q3-1.94K
13 Q3-120
13 Q2-124
13 Q1-50
12 Q4-571
12 Q3-114
12 Q2-35
Operating Income (USD) · Q
-10K-7.5K-5K-2.5K012 Q212 Q312 Q413 Q113 Q213 Q320 Q324 Q1
DSOL Operating Income (USD) by quarter
PeriodOperating Income (USD)
24 Q1-8.41K
20 Q3-1.94K
13 Q3-120
13 Q2-124
13 Q1-50
12 Q4-571
12 Q3-114
12 Q2-35
EBITDA · Q
Cash Flows · Q
EPS · Q
Expenses · Q
Cash & Debt · Q
Debt ratios · Q
Margins · Q
Return on Capital · Q
Shares Outstanding · Q
Dividends (USD) · Q
Employee Count
Book Value Per Share · Q
Total Assets · Q
PE Ratio
Free Cash Flow Yield
Price to Sales
EV/EBITDA
Price/Operating Cashflow
Price to Book
Drug Free Solution, Inc.
DSOL
Stockpicker

Video analysis: DSOL

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

News: DSOL

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.